Given the multiple mechanisms by which ROS/RNS can modulate growth promoting pathways, other mechanisms for the pro-tumor growth activity of SP are also likely involved, e.g., inhibition of NFκB signaling (17). This evidence concerns the gene NFKB1 and neoplasm.